Tagged With CRISPR

Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years

A scientist who genetically edited babies to be HIV-resistant was just sentenced to 3 years in prison. Here's how he did it and why scientists around the world are outraged.

The most mind-blowing human health discoveries of 2019

Scientists and researchers reveal 13 dark technology scenarios that keep them up at night

We'll be eating the first Crispr'd foods within 5 years, according to a geneticist who helped invent the blockbuster gene-editing tool

Dispensed: Introducing Business Insider's 10 people transforming healthcare

The world's first gene-edited reptile is a finger-sized albino lizard

Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years

Silicon Valley startups backed by celebrities like Bill Gates are using gene-editing tool Crispr to make meat without farms — and to disrupt a $200 billion industry

A Chinese scientist claims to have genetically-engineered babies — here's what editing DNA means

Chocolate could be extinct by 2050, but some companies think genetic engineering could save their supply

The Chinese scientist who claims to have edited babies' DNA has been sentenced to 3 years in prison. Here's a timeline of the controversy.

Chinese researcher behind genetically edited babies is now under investigation and suspended without pay

A Chinese researcher claims that the first gene-edited babies have been born, and scientists are disturbed

Stephen Hawking's warning that genetically altered superhumans could wipe out the rest of us doesn't mention a likely characteristic of the future elite

A medical diagnostics startup that wants to use CRISPR technology to detect diseases raised $23 million in venture funding

A blockbuster gene-editing tool has been linked to cancer -- here's how worried you should be

A blockbuster gene-editing tool has been linked to cancer -- here's how worried you should be

A troubling link has been found between a cutting-edge gene-editing technology and cancer -- and it's sending biotech stocks tumbling

The FDA just put a pause on a cutting-edge gene editing trial that hadn't started yet -- and the company's stock is dropping